To clarify incidence and clinical features of treatment‐related leukemia (TRL) due to taxane/platinum therapy in gynecological cancer patients. Click to show full abstract
To clarify incidence and clinical features of treatment‐related leukemia (TRL) due to taxane/platinum therapy in gynecological cancer patients.
               
Click one of the above tabs to view related content.